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Wireless optogenetics protects against obesity via
stimulation of non-canonical fat thermogenesis
Kazuki Tajima 1,2,3,8, Kenji Ikeda1,2,3,7,8, Yuji Tanabe4, Ella A. Thomson 4, Takeshi Yoneshiro1,2,3,
Yasuo Oguri1,2,3, Marc D. Ferro5, Ada S. Y. Poon 4,6✉ & Shingo Kajimura 1,2,3✉
Cold stimuli and the subsequent activation of β-adrenergic receptor (β-AR) potently stimu-
late adipose tissue thermogenesis and increase whole-body energy expenditure. However,
systemic activation of the β3-AR pathway inevitably increases blood pressure, a significant
risk factor for cardiovascular disease, and, thus, limits its application for the treatment of
obesity. To activate fat thermogenesis under tight spatiotemporal control without external
stimuli, here, we report an implantable wireless optogenetic device that bypasses the β-AR
pathway and triggers Ca2+ cycling selectively in adipocytes. The wireless optogenetics sti-
mulation in the subcutaneous adipose tissue potently activates Ca2+ cycling fat thermo-
genesis and increases whole-body energy expenditure without cold stimuli. Significantly, the
light-induced fat thermogenesis was sufficient to protect mice from diet-induced body-weight
gain. The present study provides the first proof-of-concept that fat-specific cold mimetics via
activating non-canonical thermogenesis protect against obesity.
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Non-shivering thermogenesis by thermogenic fat cells(brown and beige fat) plays a significant role in the reg-ulation of whole-body energy homeostasis. Recent studies
have illuminated the therapeutic potential of thermogenic fat for
the treatment of metabolic disorders because impaired adipose
thermogenesis is tightly associated with the development of
obesity and insulin resistance, whereas activation of the ther-
mogenic pathway potently improves metabolic health1,2.
The best-known stimulus of adipose tissue thermogenesis is
cold: following cold exposure, noradrenaline (NA) released from
the sympathetic nerve system (SNS) activates the β3-adrenergic
receptor (β3-AR) and its downstream signaling pathway,
including PKA and p38MAPK, which triggers adipose tissue
thermogenesis through uncoupling protein 1 (UCP1) as well as
UCP1-independent mechanisms3–6. Accordingly, extensive
efforts have been made to develop β3-AR agonists as an anti-
obesity medication that stimulates adipose tissue thermogenesis.
Consistent with the model, a selective β3-AR agonist, mirabegron,
significantly promotes adipose tissue thermogenesis and resting
metabolic rate by approximately 200 kcal per day in adult
humans7. However, a major hurdle for applying β3-AR agonists
to the treatment of obesity is that, besides the poor bioavailability,
pharmacological β3-AR activation at an effective dose to achieve
thermogenesis inevitably increases blood pressure as well8,9.
Accordingly, identifying alternative pathways that stimulate fat
thermogenesis, while avoiding cardiovascular risks, could lead to
effective and safe therapeutic interventions for obesity.
The recent identification of non-canonical UCP1-independent
thermogenesis may offer unique opportunities to enhance
adipose tissue thermogenesis10,11. We previously reported a
UCP-independent mechanism in beige fat that involves ATP-
dependent Ca2+ futile cycling through Sarco/endoplasmic
reticulum Ca2+-ATPase2b (SERCA2b) and Ryanodine Receptor 2
(RyR2)10. The Ca2+ cycling thermogenesis is evolutionally con-
served in humans, mice, and also pigs, a mammalian species that
lack a functional UCP1 protein10. Notably, enhanced Ca2+ cycling
by S107, a chemical stabilizer for the RyR2-Calstabin interaction,
potently stimulated UCP1-independent thermogenesis and pro-
tected Ucp1 null mice from hypothermia following cold expo-
sure10. A limitation in the study, however, was that S107 was
systemically administered to mice, such that we were not able to
exclude the possibility that other tissues than the adipose tissue,
such as skeletal muscle, might contribute to UCP1-independent
thermogenesis. Thus, adipocyte-specific manipulation of the Ca2+
cycling pathway would critically test the therapeutic potential of
non-canonical fat thermogenesis for the treatment of obesity.
In this regard, optogenetics is a powerful tool for temporal and
spatial manipulation of neuronal or cellular activities in vivo. The
conventional optogenetics studies required fiber optic tethering
and/or large head-mounted receivers, such that it limits the
application to metabolic studies in general. In contrast, a recent
advance in wirelessly powered optogenetics devices enabled an
efficient and stable light delivery into peripheral nerves of freely
behaving animals12. Accordingly, we develop a wireless optoge-
netics device that is implantable to the subcutaneous adipose
tissue of mice. The device is distinct from the previous attempts
in that it can stimulate peripheral cells (i.e., adipocytes) rather
than neurons. By employing this implantable wireless device, the
present study reports that light-activated Ca2+ cycling in adipo-
cytes sufficiently stimulates non-canonical thermogenesis and
protects mice against diet-induced obesity.
Results
Development of a wireless optogenetics device for adipose
tissue. We previously utilized the strong localization of
electromagnetic energy at low gigahertz frequencies to develop
wireless optogenetics devices with dimensions on the order of a
few millimeters12. However, there is very limited space between
the skin and subcutaneous fat tissue to accommodate the device.
Thus, we optimized the height of the device to be sub-millimeter
(Fig. 1a, inset), such that they can be inserted bilaterally into the
subcutaneous inguinal adipose tissue of mice (Fig. 1a and Sup-
plementary Movie 1). The device is much smaller (2 mm3, 20 mg)
than our previously reported devices, whereas the efficiency of
LED remained the same as the previous study (approximately
19%) and the power transferred to the implant at the output of
the rectifier across the surface of the resonant cavity approxi-
mately varied from 1.5 to 3 mW (time-averaged cavity input
power of 150 mW, 5% duty cycle)12. In addition, the efficiency of
the rectifier was between 20% and 60% (Supplementary Fig. 1a).
This wireless optogenetic device can be implanted entirely
underneath the skin, while the light source was not blocked by the
antenna or other circuit components. The device consists of a tiny
power-harvesting coil (2-mm diameter) with terminals connected
to a receiving circuit configured with a rectifier to drive a blue
micro-LED to activate channelrhodopsin 2 (ChR2) (Fig. 1b).
The attenuation coefficient in adipose tissues was lower than that
in the brain (adipose tissues, μ′s= 0.8 mm−1; Brain,
μ′s= 1.6 mm−1), suggesting that the wireless LED device can
stimulate ChR2-expressing cells in a broader area of adipose tis-
sues relative to the brain (Supplementary Fig. 1b). A primary bi-
layer of acrylic and Parylene-C was used to encapsulate the device
to electrically insulate the circuitry and to resist biological
degradation for chronic studies (Supplementary Fig. 1c). The
implanted devices are powered and controlled using an alumi-
num resonant cavity with a surface lattice of hexagons13. In
addition to the in vivo test setup, we also developed an in vitro
setup to rapidly depolarize cultured cells that express ChR2 upon
exposure to blue light. The optogenetic device was powered by a
crossed-slot antenna14, and they were placed on top of a glass-
bottom dish (Fig. 1c).
By using these systems, we determined the optimal light pulses
that stimulate intracellular Ca2+ influx with negligible heat
emission from the device. To this end, we performed optogenetic
stimulation in differentiated beige adipocytes expressing ChR2
with fixed 10-Hz frequency and 1, 5, or 10 ms pulse widths (1%,
5%, and 10% duty cycle, respectively) (Fig. 1d). For each set of
pulse parameters, we also measured heat emission from the
wireless device implanted into the inguinal WAT of wild-type
mice (Supplementary Fig. 1d). Based on the measurements in
intracellular Ca2+ influx and tissue temperature, we found that a
pulse width of 5 ms yielded potent intracellular Ca2+ influx,
whereas the same light pulses did not trigger heat emission from
the device in the inguinal WAT of mice (Fig. 1e). Subsequently,
we fixed the pulse width to 5 ms and varied the pulse frequency to
1, 10, or 20 Hz (0.5%, 5%, and 10% duty cycle, respectively) in
beige adipocytes expressing ChR2 and the inguinal WAT of wild-
type mice (Fig. 1f and Supplementary Fig. 1e). These results
showed that pulse width of 5 ms and 10-Hz frequency (5% duty
cycle) was optimal to stimulate intracellular Ca2+ flux with
negligible heat emission from the device in the adipose tissue
(Fig. 1g). The light-stimulated intracellular Ca2+ influx was
observed at a pulse width of 500 μs as long as the duty cycle was
maintained at 5% (Supplementary Fig. 1f, g). The light-triggered
intracellular Ca2+ influx is due to optogenetic activation of ChR2
because the optimized light-pulses with 10-Hz frequency and 5-
ms pulse width potently increased intracellular Ca2+ influx in
beige adipocytes expressing ChR2, whereas no change was seen in
control cells expressing an empty vector (Fig. 1h and Supple-
mentary Movie 2). Of note, the gradual decline in intracellular
Ca2+ level was owed to a relatively rapid decay of the calcium
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indicator Fluo-8, and thus the intercellular Ca2+ influx was
normalized by the decay rate of each assay in the following
experiments.
ChR2 is the light-gated, inwardly rectifying cation channel that
transports protons, and both monovalent (Na+, K+) and divalent
cations (Ca2+, Mg2+)15. Thus, we next examined the mechanism
by which light-activated membrane depolarization triggers
intracellular Ca2+ influx in beige adipocytes. It is worth noting
that our previous transcriptomics data16 found that L-type
voltage-dependent Ca2+ channel (Cacna1d) was highly expressed
in isolated beige adipocytes, whereas N, P/Q, R, and T-type
voltage-dependent Ca2+ channels were nearly absent (Fig. 1i).
This observation caught our attention because pharmacological
inhibition of L-type and R-type Ca2+ channels blunts
optogenetics-induced Ca2+ flux in cultured beta-cells17. Accord-
ingly, we treated beige adipocytes with pharmacological inhibitors
of voltage-dependent Ca2+ channels and examined optogenetics-
induced intracellular Ca2+ influx. We found that pharmacological
inhibition of L-type voltage-dependent Ca2+ channel by the
specific inhibitor, isradipine, completely blunted the increase in
intracellular Ca2+ influx following optogenetic stimulation. On
the other hand, blockade of R-type and T-type voltage-dependent
Ca2+ channels by SNX-482 and NNC55-0396, respectively, did
not affect the optogenetics effect (Fig. 1j). These data suggest that
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the L-type voltage-gated Ca2+ channel mediates the light-induced
membrane depolarization and triggers Ca2+ cycling in beige
adipocytes.
Next, we determined the source of the intracellular Ca2+ signal
in response to optogenetic stimulation of ChR2. Our previous
study showed that RyR2 and inositol 1,4,5-trisphosphate
receptors (IP3R1 and IP3R2) are expressed in beige adipocytes,
and that activation of RyR2 enhances Ca2+ cycling thermogenesis
in beige fat10. Accordingly, we asked the extent to which
inhibition of Ca2+ release from the ER inhibits light-induced
Ca2+ flux. To this end, we treated ChR2-expressing beige
adipocytes with inhibitors for RyR2 (Ryanodine) and/or IP3R
(2-APB). Following ChR2 activation by blue light, we found that
each inhibitor partly, but significantly, reduced intracellular Ca2+
flux. Notably, the combination of the two inhibitors completely
abolished the light-induced Ca2+ signal (Fig. 1k). These data
suggest that Ca2+ release from the ER via RyR2 and IP3R is
required for light-activated Ca2+ cycling in beige fat.
We subsequently found that optogenetic activation of Ca2+
cycling was sufficient to activate beige fat thermogenesis without
any external stimuli, such as noradrenaline (NA): the measure-
ment of cellular oxygen consumption rate (OCR) in ChR2-
expressing beige adipocytes significantly increased following light
stimulation. Consistent with the data that L-type voltage-
dependent channel blocker (isradipine) inhibited light-induced
Ca2+ influx, blockade of L-type channel completely blunted the
light-induced OCR (Fig. 1l). Importantly, optogenetic activation
of Ca2+ cycling was sufficient to stimulate glucose oxidation in
ChR2-expressing beige adipocytes, but not in control cells
(Fig. 1m).
Optogenetics device stimulates fat thermogenesis via SERCA2.
We next determined if this system sufficiently enhanced adipose
tissue thermogenesis in vivo. To do this, we generated Adipo-
ChR2 mice that expressed ChR2 selectively in mature adipocytes
by crossing Adiponectin-Cre mice with Ai32 mice that expressed
an improved ChR2 protein (ChR2 H134R) fused to EYFP only in
Cre-expressing cells (Supplementary Fig. 2a). Following implan-
tation of the wireless optogenetics devices into the inguinal WAT
of Adipo-ChR2 or littermate control mice, we monitored changes
in the adipose tissue temperature using the micro-temperature
probes (Fig. 2a). During the temperature recording, we needed to
keep the temperature probe within the inguinal adipose tissue. As
such, the inguinal adipose tissue lost some insulation (i.e., the fur
and skin), resulting in a modest reduction in adipose tissue
temperatures of control mice. In contrast, optogenetic activation
of ChR2 potently increased the inguinal WAT temperature of
Adipo-ChR2 mice (Fig. 2b). Notably, the light-stimulated adipose
tissue thermogenesis occurred selectively in the inguinal WAT
and lasted for approximately 70 min even after the end of light
stimulation, although the duration would include both thermo-
genesis and heat retention (Fig. 2c and Supplementary Fig. 2b).
Our previous study shows that Ca2+ cycling thermogenesis is
an ATP-dependent process in beige fat, and is near completely
absent in interscapular BAT (iBAT)10. We reasoned that brown
adipocytes express low levels of the ATP synthase and thus
possess low ATP synthesis capacity5,18. Hence, we examined the
tissue specificity of light-activated thermogenesis in iBAT. To this
end, we implanted the wireless optogenetic device into the
interscapular region of Adipo-ChR2 mice and control mice.
Subsequently, we monitored temperature changes in the iBAT in
response to light activation of ChR2 (Supplementary Fig. 2c). We
found that optogenetic activation of ChR2 in the interscapular
region did not trigger thermogenesis in the iBAT (Supplementary
Fig. 2d), suggesting that light-activated thermogenesis is selective
to the subcutaneous WAT.
Next, we examined if optogenetic activation of ChR2 triggers
intracellular Ca2+ influx in Ucp1 null adipocytes because Ca2+
cycling in beige adipocytes occurs independently of UCP110. We
found that the optimized light-pulses potently increased intra-
cellular Ca2+ influx in Ucp1 null beige adipocytes to a similar
degree to wild-type cells expressing ChR2 (Fig. 2d and
Supplementary Fig. 2e, f). In contrast, the optogenetic stimulation
with the same frequency and width completely failed to alter
intracellular Ca2+ influx in SERCA2-depleted adipocytes (Fig. 2d).
Consistent with the results, NA stimulated intracellular Ca2+
influx in wild-type and Ucp1 null beige adipocytes, whereas NA
failed to do so in SERCA2-depleted adipocytes (Supplementary
Fig. 3a). This increase in Ca2+ flux was accompanied by increased
OCR in wild-type and Ucp1 null beige adipocytes but not in
SERCA2-depleted adipocytes (Supplementary Fig. 3b). Together,
these data suggest that optogenetic activation of ChR2 triggers
Ca2+ cycling through SERCA2 in a UCP1-independent manner.
As an alternative approach to stimulate light-activated fat
thermogenesis, we delivered the adeno-associated virus (AAV)
expressing ChR2 or GFP control into the inguinal WAT. To
further determine the requirement of Ca2+ cycling for light-
activated thermogenesis, we expressed ChR2 in Adipocyte-
specific Serca2 KO mice that we generated in our previous
study10 (Fig. 2e, f). Consistent with the results in Adipo-ChR2
mice, optogenetic activation of ChR2 potently stimulated
thermogenesis in the inguinal WAT expressing AAV-mediated
ChR2. However, the light-activated thermogenesis was comple-
tely abrogated in the inguinal WAT of Adipo-Serca2 KO mice
Fig. 1 Wireless optogenetics implant stimulates Ca2+ influx in adipocytes. a A representative image of a freely behaving mouse with the implantable
wireless optogenetics device in the inguinal WAT (arrow heads). Scale bar, 1 mm. b Three-dimensional illustration of the implantable wireless optogenetics
device and the circuit diagram. c Schematic of optogenetic studies in cultured cells. d–g Real-time changes in intracellular Ca2+ influx following optogenetic
light stimulations with indicated pulse width (d) or pulse frequency (f). d Cells stimulated with pulse width at 1 ms, n= 104; at 5 or 10 ms, n= 140. f Cells
stimulated with pulse frequency at 1 or 10 Hz, n= 140; at 20 Hz, n= 134. Quantification of intracellular Ca2+ influx in ChR2-expressing adipocytes
stimulated with indicated pulse width (e) or pulse frequency (g) and the heat emission from the device. The data of heat emission from the device were
derived from Supplementary Fig. 1c for (e) or 1d for (g). h Real-time changes in intracellular Ca2+ influx following optogenetic light stimulation. Vector
control, n= 123; ChR2, n= 128. i Expression of indicated voltage-gated Ca2+ channels in isolated beige adipocytes (E-MTAB-3978). n= 3. j Real-time
changes (left) and quantification (right) in intracellular Ca2+ influx following optogenetic light stimulation. ChR2 with vehicle, n= 128; ChR2 with L-type
inhibitor, n= 140; ChR2 with R-type inhibitor, n= 155; ChR2 with T-type inhibitor, n= 134; Vector control with vehicle, n= 139. k Real-time changes (left)
and quantification (right) in intracellular Ca2+ influx following optogenetic light stimulation. ChR2 with vehicle, n= 105; ChR2 with RyR2 inhibitor, n= 131;
ChR2 with IP3R inhibitor, n= 120; ChR2 with RyR2 inhibitor and IP3R inhibitor, n= 140; Vector control with vehicle, n= 140. l Quantification of light-
stimulated OCR following optogenetics light stimulation. Vector control with vehicle, n= 12; Vector control with L-type inhibitor, n= 15; ChR2 with vehicle,
n= 19, ChR2 with L-type inhibitor, n= 15. m Glucose oxidation in differentiated adipocytes expressing ChR2 or vector control with or without optogenetics
light stimulation. n= 6. Data were analyzed by one-way ANOVA (j–l) or two-way ANOVA (m) by Tukey’s post hoc test. All Data are expressed as
means ± s.e.m. n.s. not significant.
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that expressed ChR2 (Fig. 2g). No change was detected in the
skeletal muscle temperature of all the mice (Supplementary
Fig. 3c). Together, these results suggest that optogenetic
activation of ChR2 triggers adipose tissue thermogenesis
in vivo, and that this effect requires Ca2+ cycling through
SERCA2 and RyR2/IP3R.
Optogenetics device increases whole-body energy expenditure.
Next, we asked if optogenetic activation of beige fat thermogen-
esis could lead to an increase in whole-body energy expenditure
without external cold stimuli. To this end, we implanted
the wireless optogenetic device into control and Adipo-ChR2
mice under a thermoneutral condition at 30 °C, where the
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f. Control with AAV-GFP, n= 4; Control with AAV-ChR2, n= 5; Adipo- Serca2 KO with AAV-ChR2, n= 5. Data were analyzed by two-way repeated
measures ANOVA (b), unpaired two-sided t-test (c, f), or two-way ANOVA (d) or one-way ANOVA (g) by Tukey’s post hoc test. All Data are expressed
as means ± s.e.m. n.s. not significant.
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SNS-mediated regulation of thermogenesis was minimized. Sub-
sequently, we measured whole-body oxygen consumption rate
(VO2) of control and Adipo-ChR2mice during 30 min before and
after a 10-min optogenetic stimulation. We found that optoge-
netic stimulation of fat thermogenesis significantly increased VO2
of Adipo-ChR2 mice by 34.9% relative to control mice (Fig. 3a).
During the metabolic cage studies, we did not detect any differ-
ence in the locomotor activity between control and Adipo-ChR2
mice (Supplementary Fig. 3d). These results suggest that the
increase in whole-body energy expenditure stems from enhanced
thermogenesis in the inguinal WAT. Notably, this increase
in whole-body energy expenditure by a 10-min optogenetic
stimulation was equivalent to the effect seen after a single
administration of β3-AR agonist (CL-316,243) at the dose of
0.01 mg kg−1 in mice under the same thermoneutral condition: a
single administration of CL-316,243 increased VO2 by 39.3%
relative to mice received a saline injection at 30 °C (Fig. 3b).
Light-activated thermogenesis protects against diet-induced
obesity. The above results motivated us to test the hypothesis that
optogenetic stimulation of adipose tissue thermogenesis protects
against diet-induced obesity. Our data suggest that the light-
induced Ca2+ cycling thermogenesis requires SERCA2; however,
the expression of SERCA2 in the adipose tissue decreases under
an obese state10. Thus, control and Adipo-ChR2 mice received
β3-agonist treatment for 5 days prior to high-fat diet studies to
induce SERCA2 expression in the inguinal WAT (Supplementary
Fig. 4a). Subsequently, wireless optogenetic devices were
implanted into the inguinal WAT of these mice. Five days fol-
lowing the device implantation, both control and Adipo-ChR2
groups received 10 min light pulses with 10-Hz frequency and 5-
ms pulse width once a day for 23 days on a high-fat diet (60%
HFD). We found that Adipo-ChR2 mice gained significantly less
body-weight than control mice at 4 days and thereafter following
light-activated thermogenesis on a HFD (P= 0.0097 by two-way
ANOVA followed by unpaired two-sided t-test). At the end of the
HFD experiments, Adipo-ChR2 mice gained significantly less
body-weight than control mice by 2.6 g on average (9.6% body-
weight loss relative to controls) (Fig. 4a). During the study, no
significant difference was detected in the food intake between the
two groups (Fig. 4b).
The light-induced changes in body-weight were due to reduced
fat mass in Adipo-ChR2 mice, but not to changes in lean mass
(Fig. 4c). Specifically, the inguinal WAT of Adipo-ChR2 mice was
significantly smaller than that of control mice at the end of HFD
studies (Fig. 4d). A similar trend was seen in the epididymal
WAT mass, while no change was noted in the iBAT and liver
weight. Histological analyses found that the inguinal WAT of
Adipo-ChR2 mice contained significantly smaller adipocytes than
control mice (Fig. 4e, f). Since beige fat biogenesis is associated
with reduced adipose tissue inflammation and fibrosis forma-
tion19–21, we examined if light-activation of thermogenesis in the
inguinal WAT altered the cellular composition of adipocytes as
well as inflammatory and fibrotic cells. However, transcriptional
analysis of the inguinal WAT of control and Adipo-ChR2 mice
found no significant difference in the expression of genes
involving in adipose tissue inflammation, fibrosis, and beige fat
biogenesis (Supplementary Fig. 4b–d). Of note, device implanta-
tion did not alter the expression of pro-inflammatory genes in the
inguinal WAT relative to sham-operated mice (Supplementary
Fig. 4e). Because our metabolic study was limited to 4 weeks of
HFD, mice did not develop notable glucose intolerance at the end
of the HFD study. Similarly, hepatic triglyceride levels remained
within a normal range. Thus, we did not find a significant
difference in systemic glucose tolerance and hepatic triglyceride
contents between control mice and Adipo-ChR2 mice at the end
of HFD studies (Supplementary Fig. 4f, g).
Discussion
Emerging evidence suggests the importance of beige fat in the
regulation of energy homeostasis, while its relative contribution to
whole-body energy metabolism has been a topic of debate5,22.
This is mainly because accurate estimation of beige fat’s con-
tribution relative to other tissues, such as skeletal muscle and
BAT, is challenging when animals are exposed to external stimuli
(e.g., cold) or hormonal cues (e.g., NA). In this regard, the
wireless optogenetic technology enabled us to selectively stimulate
ChR2-expressing adipocytes in the subcutaneous WAT of mice.
Notably, our data suggest that a 10-min stimulation of Ca2+
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cycling thermogenesis per day, i.e., fat-specific “cold-mimetics”,
potently increased total energy expenditure of adult mice by
~35% under a thermoneutral condition. This effect was sub-
stantial and was equivalent to the effect of a single administration
of β3-AR agonist, CL-316,243, at a dose of 0.01 mg kg−1 on total
energy expenditure at thermoneutrality. Given the difference in
body size/composition and pharmacokinetics between mice and
humans, the above estimation cannot be translated directly to
adult humans; however, a recent study in humans demonstrates
that oral administration of mirabegron, a FDA-approved β3-AR
selective agonist, at 200 mg increased resting metabolic rate by
~200 kcal7. According to a weight-loss prediction model in
humans, every 100 kJ (23.9 kcal) per day increment of energy
expenditure would lead to an eventual 1 kg body weight change
with half of the predicted weight change in one year (i.e., ~4 kg
for 200 kcal day−1 increase) and 95% of the change in 3 years23.
Our data suggest that light-activation of ChR2 triggers Ca2+
release from the ER via RyR2 and IP3R, which leads to Ca2+
cycling and increased ATP consumption by SERCA2. Mechan-
istically, previous studies in SERCA1 (the muscle form of SERCA)
reported that thermogenesis occurs when Ca2+ transport is
uncoupled from ATP hydrolysis by SERCA1 under certain con-
ditions, such as low ADP/ATP ratio or low Ca2+ binding affinity
of SERCA (i.e., uncoupling of ATP hydrolysis and Ca2+ trans-
port). When a Ca2+ gradient is formed across the ER or SR
membrane, heat generation by the uncoupled SERCA1’s ATPase
activity can be up to 24.7 kcal/ATP mol24,25. Mechanistically, it
has been demonstrated that micropeptides, such as Phospho-
lamban, Sarcolipin, DWORF, Myoregulin, control the Ca2+
affinity of SERCA in cardiac muscle and skeletal muscle26–30;
among them, only sarcolipin has been shown to have the SERCA
uncoupling activity. However, our RNA-seq data in beige adi-
pocytes of mice and humans did not detect any of these micro-
peptides are expressed in beige adipocytes31. Thus, we aim to
search for as-of-yet unknown regulators of SERCA2b ATP-
hydrolysis activity in beige adipocytes.
It is notable that optogenetic activation of ChR2 triggers a
sustained increase in Ca2+ cycling thermogenesis in beige fat. It
has been known that activation of L-type channel or changes in
ER Ca2+ concentration triggers Ca2+ release via RyR2 and
IP3R32–34. Also, we found that RyR2 overexpression significantly
increased UCP1-independent thermogenesis following NA
treatment, whereas blockade of RyR2 and IP3R attenuates light-
evoked intracellular Ca2+ flux and UCP1-independent thermo-
genesis10. Hence, it is conceivable that enhanced ER Ca2+ release
via RyR2/IP3R significantly contributes to the sustained Ca2+
cycling thermogenesis through several mechanisms. For instance,
PKA signaling, a major downstream signal of β3-AR, is known to
phosphorylate RyR2, leading to enhanced Ca2+ release35. In
addition, the cluster size of RyR2 controls Ca2+ release in smooth
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muscle cells36. Thus, future studies need to determine the
mechanisms through which light- or NA-stimulation alters the
open state of RyR2 and/or IP3R in adipocytes, such as time-
dependent changes in the phosphorylation and the cluster size.
In contrast to previous efforts to manipulate neural activities,
the present study stimulated adipocytes by the wireless optoge-
netic device. A current technical limitation, however, is that the
device is stable in the adipose tissue for up to 4 weeks in vivo. An
improved optogenetic device with a longer period of high-fat diet
study would warrant future studies to test the effect of light-
activated adipose tissue thermogenesis on systemic glucose
homeostasis, insulin sensitivity, and hepatic steatosis. To this end,
better encapsulation techniques should be applied to extend the
longevity of the device. Besides, we may further smooth out the
PCB corners and submerge the implant into epoxy in order to
have a homogeneous thickness of insulation around the implants.
Future designs on the device will also allow for temperature
sensing and power control to minimize the heat emission from
the device, such that light pulses of higher duty cycles can be
applied to enhance Ca2+ cycling thermogenesis.
Methods
Wireless optogenetics device. The wireless optogenetics device consists of two
main parts. The first part is a 2-turn power receiving coil (2-mm diameter) made of
copper wire (200-μm diameter). It extracts RF energy coupled from the cavity to
the mouse in the in vivo experiments. The second part is the rectifier and micro-
LED. The rectifier converts the RF energy into direct current to drive the micro-
LED. It was implemented as a two-stage voltage doubling circuit using Schottky
diodes (Skyworks, SMS7630-061). The micro-LED (Cree, DA2432) is in bare die
form to save space. All components were bonded to a circuit board made of Rogers
Printed Circuit Board (PCB) material for ease of cutting. The dimension of the
circuit board is 1.6 by 1.8 mm. The overall height of the implant is dominated by
the height of the capacitors, which are 0.3 mm. The entire device was encapsulated
in epoxy and coated by Parylene-C to form a biocompatible and impermeable
membrane protecting the internal electronics. Parylene-C was deposited using an
SCS Labcoater 2 to a thickness of 2 µm to ensure pinhole-free films. A 3-(tri-
methoxysilyl) propyl methacrylate (A-174 Silane) solution was used as an adhesion
promoter to maximize the adhesion of the film to the surface of the device. To
estimate the accelerated rate test of the wireless LED device, we simulated degra-
dation of the implants using reactive accelerated aging (RAA) techniques37. Briefly,
the implants were soaked into a solution of 20 mM hydrogen peroxide H2O2 in
Phosphate Buffer Saline (PBS) and were heated up to 60 °C, which mimics an
immune system attack with accelerated reactive oxygen species (ROS) chemical
reaction38. We refreshed the solution with additional H2O2 every 11 h for 5 days in
order to maintain proper chemical reactions. At the end of the experiment, the
implants were inspected under a microscope. To determine the light attenuation in
adipose tissue, we measured the transmission of 470 nm light from the CREE
micro-LED in freshly isolated adipose tissues (inguinal and epididymal WAT) and
the brain of mice using a Thorlabs PM100D optical power meter. Tissues were
placed between two glass slides, and the thickness was measured using a caliper.
Transmission percentages were calculated as a ratio of the optical power measured
through 2 mm of tissue or an air gap, to the power measured directly through the
glass slides with no air gap. Based on the measurement of the attenuation coeffi-
cient in adipose tissues and a previous report showing that the threshold of sti-
mulation for ChR2 is approximately 1 mWmm−239, it is estimated that the
wireless LED device can stimulate ChR2-expressing cells in a surrounding region
with a radius greater than 0.75 mm, a broader area of adipose tissues relative to
the brain.
Optogenetics device for cultured cells. A board with 24 LED’s was fabricated to
enable optogenetic testing with a seahorse cell culture plate. Blue LED’s (BIVAR
R20BLU-4-0045) were used, which have a peak wavelength of 470 nm, and a
typical luminous intensity of 8000 mcd. The LED’s were soldered on a prototyping
board, in series with a 47-Ohm resistor to limit current. One LED was aligned with
the center of each well on the seahorse plate. 4-Volt supplies were used to power
the LED’s. An Arduino program was used to control the LED’s, with a frequency of
10 Hz and a duty cycle of 50%. 2N7000 MOSFET’s were used as switches to
selectively control the power to the LED’s.
Animals. All animal experimental procedures were performed in compliance with
all relevant ethical regulations applied to the use of small rodents. The animal
protocol was approved by the UCSF Institutional Animal Care and Use Com-
mittee. For the generation of adipocyte-specific express channelrhodopsin-2
(Adipo-ChR2) mice, Ai32 (RCL-ChR2 (H134R) /EYFP) mice (male, Bl6 back-
ground) were obtained from the Jackson Laboratory (Stock No: 024109) and
crossed to Adiponectin-Cre mice. We also used male adipocyte-specific Serca2 KO
mice (Adipo-Serca2 KO, Adiponection-Cre × Atp2a2flox/flox) in the Bl6 background
as described previously10. For metabolic cage studies, we obtained male Bl6 mice
from the Jackson Laboratory (Stock No: 000664). All the mice had free access to
food and water, 12 h light–dark cycles, and were caged at an ambient temperature
of 22 °C or thermoneutrality (30 °C). For the study of stimulation with optogenetic
wireless implant on a high-fat diet, Adipo-ChR2 mice (8–9 weeks old, male) and
the littermate control mice (male) were treated with β3 adrenergic receptor agonist
(CL-316, 243 (Sigma)) at 1 mg kg−1 for 5 days prior to the implantation surgery to
induce SERCA2 expression in the adipose tissue. The mice were implanted with
optogenetic wireless devices on the bilateral inguinal adipose tissues under iso-
flurane anesthesia (2–3%). Five days after the implantation, all the mice received
light-pulses with 10-Hz frequency and 5-ms pulse width for 10 min once a day on a
high-fat diet (D12492, Research diet). In this protocol, we minimize handling
stress, and no change in animal behavior and food intake was noted.
Tissue temperature recording. For tissue temperature recording, type T ther-
mocouple probes and/or fiber optic temperature probe were implanted into the
adipose tissue of mice under anesthesia (Urethane at 1.3 g kg−1). Device implan-
tation was performed according to the procedures described in previous stu-
dies10,40. Tissue temperature was recorded by TC-2000 Meter (Sable Systems
International) or Reflex fiber signal conditioner (Neoptix). The Neoptix T1 fiber
optic temperature probe has a response time of less than 500 ms and the size of the
sensitive area is 300 microns in diameter. Temperature recording was initiated
once tissue temperature was stabilized prior to light-pulses.
Metabolic analyses. Whole-body energy expenditure and locomotor activity
(beam break counts) were measured by using a comprehensive lab animal mon-
itoring system (CLAMS) (Columbus Instruments). For the study of stimulation
with optogenetic wireless implants, devices were implanted into the inguinal WAT
of Adipo-ChR2 mice and the littermate control mice before CLAMS analysis. Five
days after the implantation, whole-body oxygen consumption rate (VO2), loco-
motor activity, and food intake were monitored at thermoneutrality (30 °C) by
CLAMS. During the study, VO2 was measured before and after optogenetic sti-
mulation at 10 Hz with 5-ms pulses for 10 min. For the study of β3-AR agonist
(CL-316,243) administration, VO2 was measured before and after a single injection
with CL-316,243 at 0.01 mg kg−1 or saline in wild-type mice at 14–16 weeks old at
thermoneutrality (30 °C). The measurement was the average values of VO2 for
30 min before and after optogenetic stimulation or a i.p. injection of CL-316,243
or saline. Fat mass and lean mass were measured by Body Composition Analyzer
EchoMRI (Echo Medical Systems). For glucose tolerance test experiments, after 6 h
of fasting, the mice were injected intraperitoneally with glucose (2.0 g kg−1). To
measure liver triglyceride contents, liver tissues were homogenized in 350 μl
ethanolic KOH (100% EtOH: 30% KOH= 2:1) and incubated at 55 °C overnight.
Subsequently, tissue lysates were brought volume to 1 ml with 50%EtOH. After
centrifugation, the supernatant was incubated with 1M MgCl2 on ice for 10 min.
Amounts of triglycerides were determined by an Infinity Triglycerides kit
(Thermo).
Administration of AAV vectors. Adipo-Serca2 KO mice (14–18 weeks old) and
age-matched wild-type mice were treated with β3 adrenergic receptor agonist (CL-
316, 243) at 1 mg kg−1 for 5 days. Subsequently, AAV expressing ChR2 (AAV8-
EF1a-hChR2 (H134R)-EYFP; the Neuroscience Gene Vector and Virus Core of
Stanford University) or control GFP (AAV8-CAG-EGFP) were injected into the
inguinal WAT of mice (viral titer: 8.5 × 109 GC per mice). AAV was injected to six
locations in the inguinal WAT to equally distribute the expression of ChR2 or GFP
(5 μl volume at the viral tire of 1.7 × 109 GC μl−1 per injection). Fourteen days after
the AAV injection, tissue temperature was recorded in response to optogenetic
light pulses. After temperature recording, the expression of ChR2 was confirmed by
measuring the mRNA expression by qRT-PCR.
Virus construction. Lentiviral vectors were obtained from Add-gene (pLenti-
EF1a-hChR2(H134R)-EYFP-WPRE, Catalog #20942) and GeneCopoeia (shRNA
targeting Atp2a2, CS-MSH028715-33-LVRU6GH; scrambled control,
CSHCTR001-LVRU6GH). HEK293T cells were seeded at 70,000 cells per cm2 in
15 cm tissue culture dishes in 20 ml media (DMEM, 10% FBS) and incubated
overnight at 37 °C and 5% CO2. Twenty-four hours after cell plating, 12 µg of
lentiviral transfer vector was transfected together with 7 µg psPAX2 (Addgene
#12260) and 3 µg pMD2.G (Addgene #12259) using 50 µl jetPRIME transfection
reagent (Polyplus). Seventy-two hours after transfection, cell culture media were
collected and filtered. Lentivirus purification was performed at UCSF Viral Core.
Beige adipocytes were incubated in the virus overnight in the medium containing
6 μg ml−1 polybrene. Blasticidin at 10 µg ml−1 or hygromycin at 200 µg ml−1 was
used for selection.
Cell culture. Ucp1 KO beige adipocytes were generated by immortalizing the
stromal vascular fraction (SVF) from the inguinal WAT of Prdm16 Tg x Ucp1 KO
mice10. SERCA2-depleted beige adipocytes were generated by infecting lentiviral
shRNA targeting mouse Atp2a2 (CS-MSH028715-33-LVRU6GH) to immortalized
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beige adipocytes in our previous study10. Beige adipocyte differentiation was
induced by treating confluent preadipocytes with DMEM containing 10% FBS, 0.5
mM isobutylmethylxanthine, 125 nM indomethacin, 2 μg ml−1 dexamethasone,
850 nM insulin, and 1 nM T3, and 0.5 μM rosiglitazone41. Two days after induc-
tion, cells were switched to a maintenance medium containing 10% FBS, 850 nM
insulin, 1 nM T3, and 0.5 μM rosiglitazone.
Intracellular Ca2+ flux assays. Wild-type, Ucp1 KO, and Serca2-depleted beige
adipocytes expressing vector or ChR2 were differentiated on collagen-coated glass-
bottom dishes according to the beige fat differentiation protocol41. Intercellular Ca2
+ levels were determined by using the Fluo-8 No Wash Calcium Assay kit (Abcam,
ab112129). Differentiated adipocytes were incubated with Fluo-8 in calcium-free
Hanks’ balanced salt solution (HHBS) at 37 °C for 30 min and subsequently
incubated at room temperature for an additional 30 min. Subsequently, the buffer
was replaced by HHBS, including 1 mM CaCl2, followed by the intracellular Ca2+
flux assays. For experiments using Ca2+ channel inhibitors, differentiated beige
adipocytes expressing ChR2 were incubated with L-type Ca2+ channel blocker
(isradipine at 10 µM), R-type Ca2+ channel blocker (SNX-482 at 100 nM), or T-
type Ca2+ channel blocker (NNC55-0396 at 3 µM), RyR2 receptor blocker (Rya-
nodine at 100 µM) or IP3R blocker (2-APB at 50 µM) for 90 min prior to opto-
genetics light stimulation. Intracellular Ca2+ level was monitored using a Revolve
microscope (ECHO Laboratories) equipped with a 20× objective. The fluorescence
was detected by the fluorescence filter Cube 2002 (ECHO Labolatories: Excitation
470/40 nm, dichroic 495 nm, emission 525/50 nm). Immediately after optogenetic
light stimulation or adding noradrenaline at 1 µM, fluorescence intensity of dif-
ferentiated adipocytes was monitored. Optogenetic light stimulation was delivered
at 10 Hz with 5-ms width for 30 s. Image analyses were performed using the ImageJ
software (https://imagej.nih.gov/ij/download.html). Specifically, the circular
regions of interest (ROI) was placed onto individual differentiated adipocytes.
Time-course changes in intracellular Ca2+ levels were recorded by quantifying the
pixel intensity of the ROI and expressed as delta fluorescence ratio F/F0 or delta
F/F0 relative to control, where F is the fluorescence intensity at a given time and F0
is the initial resting fluorescence intensity prior to stimuli. Background signal
(signal from the area without cells) was subtracted from all data.
Cellular oxygen consumption assays (OCR). Oxygen consumption rate (OCR)
in cultured adipocytes was measured using the Seahorse XFe Extracellular Flux
Analyzer (Agilent) in a 24-well plate. For the measurement of NA-induced OCR,
differentiated adipocytes were incubated in the XF assay media in the presence or
absence of NA at 1 µM. For the measurement of optogenetics-induced cellular
respiration, OCR in differentiated adipocytes expressing vector or ChR2 was
measured in the XF assay media before and after optogenetics stimulation. Cells
were stimulated with optogenetics light at 10 Hz with 50-ms width for 10 min at
37 °C. To inhibit L-type Ca2+ channel, cells were incubated with isradipine at
10 µM or vehicle for 90 min prior to light stimulation. Light-induced OCR (%)
values were calculated by OCR after light stimulation normalized by basal OCR
prior to light stimulation. The XF assay medium was supplemented with 1 mM
sodium pyruvate, 2 mM GlutaMaxTM-I, and 25 mM glucose.
Glucose oxidation. Differentiated adipocytes were incubated in DMEM containing
2% FBS for 2 h. After washing in PBS, cells were incubated in 1 ml of KRB/HEPES
buffer that contained 1.8 mM CaCl2, 2% BSA, 15 mM glucose, 200 nM adenosine,
and 0.5 μCi [1-14C] glucose. Cells received optogenetic light stimulation on a board
with 24 LED’s at 10 Hz with 50-ms width for 30 min at 37 °C. Subsequently, 350 μl
of 30% hydrogen peroxide was added in each well, and [14C] CO2 from each well
was trapped in the smears supplemented with 300 μl of 1 M benzethonium
hydroxide solution at room temperature for 20 min. Glucose oxidation was
quantified by counting the radioactivity of trapped [14C] CO2 using a scintillation
counter.
Histology. For hematoxylin and eosin (H&E) staining, adipose tissues were fixed
in 4% paraformaldehyde, followed by 70% ethanol. Tissues were embedded in
paraffin, sectioned at 5 µm, and stained with H&E. Adipocyte images were acquired
using a Revolve microscope (ECHO Laboratories), and the cellular size was
quantified by using the Image J software. For the adipocyte size quantification, we
measured at least 500 cells per mouse.
Quantitative RT-PCR. Total RNA was extracted from the adipose tissues using
RiboZol reagents (AMRESCO) followed by the RNeasy mini-kit (Qiagen Inc.,
Valencia, CA). cDNA was synthesized by iScript cDNA Synthesis kit (BioRad)
according to the provided protocol. Quantitative real-time PCR (qRT-PCR) was
performed using an ABI ViiA™7 PCR cycler (Applied Biosystems). Each sample
was run in duplicate, and the expression levels of each gene were normalized to
36B4. Relative mRNA levels were determined by the ΔΔ Ct method and normalized
to an internal calibrator specific to each gene using the formula 2−ΔΔCT. Primer
sequences are provided in Supplementary Table 1.
Statistical analysis. Statistical analyses were performed using GraphPad Prism 7.0
(GraphPad Software, Inc., La Jolla, CA). All data are expressed as means ± SEM.
Comparisons between the two groups were analyzed using the paired or unpaired
t-test as appropriate. One-way or two-way ANOVA, followed by Tukey’s test was
used for multiple group comparisons. Two-way repeated-measures ANOVA fol-
lowed by post-hoc paired/unpaired t-test with Bonferroni’s correction was used for
the comparisons of repeated measurements. P values below 0.05 were considered
significant throughout the study.
Data availability
The source data underlying Figs. 1d–m, 2b–d, f, g, 3a, b, 4a–d, f, and Supplementary
Figs. 1a, b, d–g, 2a, b, d–f, 3a–d, and 4a–g are provided as a Source Data file. All other
relevant data of this study are available from the corresponding authors upon reasonable
request. A reporting summary is available as a Supplementary Information file.
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